CYP2W1 and colorectal carcinoma: Although CYP2W1 substrates comprise various endogenous compounds, including arachidonic acid, retinoic acid, and lysophospholipids [60, 61], additional substrates for this enzyme need to be investigated and further studies are required to verify if CYP2W1 is a specific drug target in CRC treatment.